引用次数
引用: 27,080
H-指数: 81
I10-指数 : 225
出版物: 553
Innovative Troxler-free Measurement of Macular Pigment and Lens Density with Correction of the Former for the Aging Lens
Richard A. Bone , Anirbaan Mukherjee , Jeffrey B. Morris
Investigative Ophthalmology & Visual Science 53 ( 14) 3362 -3362
2012
Indicators of quality of care for frail aged patients in the acute care setting
C. Brand , M. Martin-Khan , J. Tropea , L. Gray
Australasian Journal on Ageing 29 24 -24
2010
Indicators of quality of care for patients with dementia in the acute care setting
G Byrne , L Gray , R Jones , M Martin-Khan
Australasian Journal on Ageing 29 25 -25
2010
Outcome indicators to measure quality of care in hospital
C. Brand , M. Martin-Khan , J. Tropea , L. Gray
Australasian Journal on Ageing 31 37 -38
1
2012
RARE CASE OF SEVERE COVID-19 IN OTHERWISE HEALTHY INFANT AT 4 DAYS OF LIFE
J. Morris , A. Gubbels , C. Meyer , N. P. Shah
Journal of Investigative Medicine 69 ( 2) 469 -470
2021
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION IN NEONATES SEEN IN PEDIATRIC EMERGENCY DEPARTMENT REQUIRING HOSPITALIZATION: A CASE SERIES
J. Morris , A. Gubbels , C. Meyer , N. P. Shah
Journal of Investigative Medicine 69 ( 2) 626 -626
2021
Final response data of a phase II study of capecitabine and oxaliplatin (CAPOX) in advanced adenocarcinoma of the small bowel or ampulla of Vater
M. J. Overman , G. R. Varadhachary , E. Lin , J. Morris
Journal of Clinical Oncology 26 4538 -4538
3
2008
Toenail Chromium Concentration and Metabolic Syndrome among Korean Adults.
Jakyung Son , J. Morris , Kyong Park
International Journal of Environmental Research and Public Health 15 ( 4) 682
5
2018
Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patient Outcome
J.A. Ajani , P.F. Mansfield , C.H. Crane , T.T. Wu
Journal of Clinical Oncology 23 ( 6) 1237 -1244
223
2005
Immune Response to Human Papillomavirus Type 16 E6 Oncoprotein
L. Gao , B. Chain , C. Sinclair , L. Crawford
Immunology of Human Papillomaviruses 219 -226
1994
Molecular predictors of response to antiangiogenic therapy in HCC: Data from bevacizumab and erlotinib phase II study.
A. O. Kaseb , J. Morris , M. Hassan , M. Iwasaki
Journal of Clinical Oncology 28 ( 15_suppl) 4046 -4046
1
2010
Effect of Age on Risk of Second Primary Colorectal Cancer
I. Shureiqi , C. D. Cooksley , J. Morris , A. S. Soliman
Journal of the National Cancer Institute 93 ( 16) 1264 -1266
46
2001
Size and number of examined lymph nodes impacts outcome in patients with stage II colorectal cancer
L. Chirieac , Y. Suehiro , A. Niemisto , I. Shmulevich
Journal of Clinical Oncology 22 3507 -3507
2
2004
A phase II study of capecitabine and oxaliplatin (CAPOX) in metastatic adenocarcinoma of the small bowel (SBA) or ampulla of Vater
M. J. Overman , S. Chedid , J. Morris , S. Waldrum
Journal of Clinical Oncology 24 14025 -14025
2006
Preliminary results from a phase II study of infusional 5-FU, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer (mCRC)
S. Kopetz , J. L. Abbruzzese , C. Eng , R. B. Adinin
Journal of Clinical Oncology 24 ( 18_suppl) 3579 -3579
22
2006
O-27 Epithelial proliferation (Ki67) is prognostic in symptomatic but not screen detected breast cancers (SDBC)
N.J. Bundred , W.F. Knox , A. Cramer , M. Wilson
Ejc Supplements 8 ( 6) 10
2
2010
DNA repair gene polymorphisms and risk of pancreatic cancer.
D. Li , H. Suzuki , B. Liu , J. Morris
Clinical Cancer Research 15 ( 2) 740 -746
65
2009
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer.
C. H. Lieu , H. T. Tran , Z. Jiang , M. Mao
Journal of Clinical Oncology 29 3533 -3533
122
2011
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer
S. M. Reddy , S. Kopetz , J. Morris , N. Parikh
Investigational New Drugs 33 ( 4) 977 -984
23
2015
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
M.J. Overman , V. Morris , B. Kee , D. Fogelman
Annals of Oncology 27 ( 6) 1068 -1074
21
2016